We are live on !
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$11.8M
(-7.1%)
Cap. Flow
-$36K
Cap. Flow % of AUM
Cap. Flow %
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
42.4%
Holding
114
New
12
Increased
11
Reduced
33
Closed
5
Avg Time Held
4.3
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Telesis Bio, Inc. Common Stock
TBIO
|
+$1.21M |
| 2 |
PubMatic
PUBM
|
+$806K |
| 3 |
Invesco S&P 500 Equal Weight Energy ETF
RSPG
|
+$709K |
| 4 |
Shell
SHEL
|
+$648K |
| 5 |
Lincoln Educational Services
LINC
|
+$455K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axcelis
ACLS
|
+$967K |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$805K |
| 3 |
Microsoft
MSFT
|
+$696K |
| 4 |
PVG
PRETIUM RESOURCES INC.
PVG
|
+$666K |
| 5 |
INVE Technologies, Inc. Common Stock
INVE
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.05% |
| 2 | Healthcare | 20.89% |
| 3 | Energy | 11.21% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Synchrony
SYF
$24B
| $962K | 0.62% |
27,650
-2,500
| -8% | -$105K |
2018 Q3
14 quarters
|
|
52
Builders FirstSource
BLDR
$5.88B
| $928K | 0.6% |
14,373
-449
| -3% | -$32.6K |
2021 Q1
4 quarters
|
|
53
Williams Companies
WMB
$87.2B
| $915K | 0.59% |
27,380
| – | – |
2013 Q4
33 quarters
|
|
54
Regeneron Pharmaceuticals
REGN
$81.4B
| $888K | 0.58% |
1,272
| – | – |
2021 Q1
4 quarters
|
|
55
Insight Molecular Diagnostics
IMDX
$98.5M
| $861K | 0.56% |
28,908
| – | – |
2019 Q4
9 quarters
|
|
56
Chegg
CHGG
$81.3M
| $839K | 0.54% |
23,115
| – | – |
2014 Q2
31 quarters
|
|
57
Kopin
KOPN
$594M
| $816K | 0.53% |
322,700
| – | – |
2016 Q2
23 quarters
|
|
|
58
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$664M
| $799K | 0.52% |
+11,865
| New | +$709K |
2022 Q1
0 quarters
|
|
|
59
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $774K | 0.5% |
+8,009
| New | +$1.21M |
2022 Q1
0 quarters
|
|
60
Immersion
IMMR
$231M
| $762K | 0.49% |
137,020
-1,900
| -1% | -$9.8K |
2019 Q1
12 quarters
|
|
61
CNX Resources
CNX
$5.31B
| $750K | 0.49% |
36,200
| – | – |
2021 Q1
4 quarters
|
|
62
Exagen
XGN
$187M
| $711K | 0.46% |
88,600
| – | – |
2021 Q3
2 quarters
|
|
63
Franklin Master Intermediate Income Trust
PIM
$146M
| $691K | 0.45% |
192,902
-4,250
| -2% | -$15.4K |
2013 Q4
33 quarters
|
|
64
First American
FAF
$6.63B
| $671K | 0.44% |
10,350
-100
| -1% | -$7.11K |
2013 Q4
33 quarters
|
|
|
65
Shell
SHEL
$303B
| $671K | 0.44% |
+12,210
| New | +$648K |
2022 Q1
0 quarters
|
|
66
Intellicheck
IDN
$43.4M
| $665K | 0.43% |
260,780
| – | – |
2021 Q2
3 quarters
|
|
67
Emerson Electric
EMR
$90.1B
| $569K | 0.37% |
5,800
| – | – |
2014 Q1
32 quarters
|
|
68
Novartis
NVS
$286B
| $567K | 0.37% |
6,460
| – | – |
2013 Q4
33 quarters
|
|
69
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
| $546K | 0.35% |
3,460
-2,700
| -44% | -$421K |
2017 Q4
17 quarters
|
|
70
iShares Biotechnology ETF
IBB
$10.3B
| $543K | 0.35% |
4,170
-390
| -9% | -$50.8K |
2016 Q2
23 quarters
|
|
|
BKI
71
DELISTED
Black Knight, Inc. Common Stock
BKI
| $540K | 0.35% |
9,318
-550
| -6% | -$36.3K |
2017 Q4
17 quarters
|
|
72
Meta Platforms (Facebook)
META
$1.81T
| $534K | 0.35% |
2,400
| – | – |
2014 Q3
30 quarters
|
|
73
Ford
F
$49.6B
| $514K | 0.33% |
30,375
| – | – |
2020 Q3
6 quarters
|
|
74
Becton Dickinson
BDX
$52.2B
| $513K | 0.33% |
1,978
-410
| -17% | -$106K |
2013 Q4
33 quarters
|
|
75
Cenovus Energy
CVE
$60.7B
| $480K | 0.31% |
+28,800
| New | +$437K |
2022 Q1
0 quarters
|
|
Similar funds
ACA
CCM
CIA
EG
ANHIM
WS
CBOR
NWMG
Penbrook Management's Q1 2022 Portfolio in Review
As of Q1 2022, Penbrook Management held 114 positions worth $154M, down 7.1% from $166M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Penbrook Management's Q1 2022 filing shows 12 new, 11 increased, 33 reduced and 5 closed positions. Its largest new stake was Telesis Bio, Inc. Common Stock: 8,009 shares worth $774K. The largest sale was Axcelis, an estimated $967K.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Energy.
- Penbrook Management's largest Q1 2022 buy was Telesis Bio, Inc. Common Stock: 8,009 shares worth $774K.
- Penbrook Management added most to PubMatic in Q1 2022, an estimated $806K increase.
- Penbrook Management's biggest Q1 2022 reduction was Axcelis, cutting an estimated $967K.
- Penbrook Management fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $805K.
- Penbrook Management's ten largest holdings make up 42% of its $154M portfolio in Q1 2022.
- Penbrook Management opened 12 new positions and closed 5 in Q1 2022.
- Penbrook Management's portfolio value fell 7.1% quarter-over-quarter to $154M.
Based on Penbrook Management's 13F filing for Q1 2022, filed 26 Apr 2022.